Patients 0 8 0 8 O
who 9 12 9 12 O
received 13 21 13 21 O
chemotherapy 22 34 22 34 B-treatment
directed 35 43 35 43 O
at 44 46 44 46 O
the 47 50 47 50 O
present 51 58 51 58 O
disease 59 66 59 66 O

Patients 0 8 67 75 O
with 9 13 76 80 O
GOG 14 17 81 84 B-clinical_variable
Performance 18 29 85 96 I-clinical_variable
Grade 30 35 97 102 I-clinical_variable
of 36 38 103 105 O
3 39 40 106 107 B-lower_bound
or 41 43 108 110 O
4 44 45 111 112 B-upper_bound

Patients 0 8 113 121 O
with 9 13 122 126 O
a 14 15 127 128 O
history 16 23 129 136 O
of 24 26 137 139 O
other 27 32 140 145 O
invasive 33 41 146 154 B-cancer
malignancies 42 54 155 167 I-cancer
, 54 55 167 168 O
with 56 60 169 173 O
the 61 64 174 177 O
exception 65 74 178 187 O
of 75 77 188 190 O
non 78 81 191 194 B-cancer
- 81 82 194 195 I-cancer
melanoma 82 90 195 203 I-cancer
skin 91 95 204 208 I-cancer
cancer 96 102 209 215 I-cancer
within 103 109 216 222 O
the 110 113 223 226 O
last 114 118 227 231 B-upper_bound
five 119 123 232 236 I-upper_bound
years 124 129 237 242 I-upper_bound

Patients 0 8 243 251 O
with 9 13 252 256 O
renal 14 19 257 262 B-chronic_disease
abnormalities 20 33 263 276 I-chronic_disease
, 33 34 276 277 O
such 35 39 278 282 O
as 40 42 283 285 O
pelvic 43 49 286 292 B-treatment
kidney 50 56 293 299 I-treatment
, 56 57 299 300 O
horseshoe 58 67 301 310 B-treatment
kidney 68 74 311 317 I-treatment
, 74 75 317 318 O
or 76 78 319 321 O
renal 79 84 322 327 B-treatment
transplantation 85 100 328 343 I-treatment
, 100 101 343 344 O
that 102 106 345 349 O
would 107 112 350 355 O
require 113 120 356 363 O
modification 121 133 364 376 O
of 134 136 377 379 O
surgical 137 145 380 388 B-treatment
lymph 146 151 389 394 I-treatment
node 152 156 395 399 I-treatment
assessments 157 168 400 411 I-treatment

Preoperative 0 12 412 424 O
evaluation 13 23 425 435 O
to 24 26 436 438 O
rule 27 31 439 443 O
- 31 32 443 444 O
out 32 35 444 447 O
extra 36 41 448 453 B-chronic_disease
- 41 42 453 454 I-chronic_disease
uterine 42 49 454 461 I-chronic_disease
disease 50 57 462 469 I-chronic_disease
may 58 61 470 473 O
include 62 69 474 481 O
CT 70 72 482 484 O
scan 73 77 485 489 O
, 77 78 489 490 O
MRI 79 82 491 494 O
, 82 83 494 495 O
or 84 86 496 498 O
ultrasound 87 97 499 509 O

must 0 4 510 514 O
be 5 7 515 517 O
surgical 8 16 518 526 O
candidates 17 27 527 537 O
for 28 31 538 541 O
complete 32 40 542 550 O
hysterectomy 41 53 551 563 B-treatment
and 54 57 564 567 O
bilateral 58 67 568 577 B-treatment
salpingo 68 76 578 586 I-treatment
- 76 77 586 587 I-treatment
oophorectomy 77 89 587 599 I-treatment
and 90 93 600 603 O
pelvic 94 100 604 610 B-treatment
and 101 104 611 614 I-treatment
aortic 105 111 615 621 I-treatment
lymphadenectomy 112 127 622 637 I-treatment

must 0 4 638 642 O
have 5 9 643 647 O
GOG 10 13 648 651 B-clinical_variable
performance 14 25 652 663 I-clinical_variable
status 26 32 664 670 I-clinical_variable
0 33 34 671 672 B-lower_bound
, 34 35 672 673 O
1 36 37 674 675 O
, 37 38 675 676 O
or 39 41 677 679 O
2 42 43 680 681 B-upper_bound

must 0 4 682 686 O
have 5 9 687 691 O
an 10 12 692 694 O
estimated 13 22 695 704 O
survival 23 31 705 713 O
greater 32 39 714 721 O
than 40 44 722 726 O
or 45 47 727 729 O
equal 48 53 730 735 O
to 54 56 736 738 O
3 57 58 739 740 B-lower_bound
months 59 65 741 747 I-lower_bound

must 0 4 748 752 O
not 5 8 753 756 O
have 9 13 757 761 O
received 14 22 762 770 O
neoadjuvant 23 34 771 782 B-treatment
chemotherapy 35 47 783 795 I-treatment
for 48 51 796 799 O
the 52 55 800 803 O
present 56 63 804 811 O
disease 64 71 812 819 O

